Advertisement

Related Videos

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Opportunities to Optimize Cancer Policies Panel Discussion

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Advertisement

Advertisement




Sep
29
Today In Oncology
Cancer Statistics 2026: What Every Medical Oncologist Should Know
Long-Term Disease Control From SBRT Equal to Surgery in Localized Prostate Cancer
Short-Course SBRT Better Preserves Physical Function Before Pancreatic Cancer Surgery
Ultra-Low-Dose Radiation Therapy May Relieve Bone Pain From Multiple Myeloma
New Prognostic Model May Improve Risk Classification in Metastatic Clear Cell RCC
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo